Fresenius Kabi USA Discontinued
FDA Approved Drugs

Fresenius Kabi USA Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 146
  • Latest Approval Date Feb 10, 2025
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
581
View
Unclassified
18
View
Discontinued
146
View
RX
417
View
Company Overview

Company

Fresenius Kabi USA Discontinued

Country

U.S.A

Website

Visit Website

Email

contactus@fresenius-kabi.com

Social Profiles

Company Snapshot

Fresenius Kabi USA Discontinued

Three Corporate DriveLake Zurich, Illinois 60047

U.S.A

www.fresenius-kabi.com/us/ contactus@fresenius-kabi.com View on Map
FDA Approved Drug Records ( 146 records )
1998
30 Apr
Discontinued Application: 75015

Drug Name

ACYCLOVIR SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

1998-04-30

75015 / 1

Active Ingredient

ACYCLOVIR SODIUM

Application Number

75015

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

1998-04-30

Regulatory Status

Discontinued

2015
09 Dec
Discontinued Application: 205605

Drug Name

AMIKACIN SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/ML

Approval Date

2015-12-09

205605 / 1

Active Ingredient

AMIKACIN SULFATE

Application Number

205605

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/ML

Approval Date

2015-12-09

Regulatory Status

Discontinued

2010
28 Jun
Discontinued Application: 90088

Drug Name

ANASTROZOLE

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2010-06-28

90088 / 1

Active Ingredient

ANASTROZOLE

Application Number

90088

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2010-06-28

Regulatory Status

Discontinued

2015
23 Mar
Discontinued Application: 201811

Drug Name

ARGATROBAN

Product Number

1

Dosage Form

-

Strength

250MG/2.5ML (100MG/ML)

Approval Date

2015-03-23

201811 / 1

Active Ingredient

ARGATROBAN

Application Number

201811

Product Number

1

Dosage Form

-

Strength

250MG/2.5ML (100MG/ML)

Approval Date

2015-03-23

Regulatory Status

Discontinued

1986
07 Oct
Discontinued Application: 71050

Drug Name

ASTRAMORPH PF

Product Number

1

Dosage Form

-

Strength

0.5MG/ML

Approval Date

1986-10-07

71050 / 1

Active Ingredient

MORPHINE SULFATE

Application Number

71050

Product Number

1

Dosage Form

-

Strength

0.5MG/ML

Approval Date

1986-10-07

Regulatory Status

Discontinued

1986
07 Oct
Discontinued Application: 71051

Drug Name

ASTRAMORPH PF

Product Number

1

Dosage Form

-

Strength

0.5MG/ML

Approval Date

1986-10-07

71051 / 1

Active Ingredient

MORPHINE SULFATE

Application Number

71051

Product Number

1

Dosage Form

-

Strength

0.5MG/ML

Approval Date

1986-10-07

Regulatory Status

Discontinued

1986
07 Oct
Discontinued Application: 71052

Drug Name

ASTRAMORPH PF

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

1986-10-07

71052 / 1

Active Ingredient

MORPHINE SULFATE

Application Number

71052

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

1986-10-07

Regulatory Status

Discontinued

1986
07 Oct
Discontinued Application: 71053

Drug Name

ASTRAMORPH PF

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

1986-10-07

71053 / 1

Active Ingredient

MORPHINE SULFATE

Application Number

71053

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

1986-10-07

Regulatory Status

Discontinued

2010
13 May
Discontinued Application: 79045

Drug Name

BICALUTAMIDE

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2010-05-13

79045 / 1

Active Ingredient

BICALUTAMIDE

Application Number

79045

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2010-05-13

Regulatory Status

Discontinued

2017
06 Nov
Discontinued Application: 205004

Drug Name

BORTEZOMIB

Product Number

1

Dosage Form

-

Strength

3.5MG/VIAL

Approval Date

2017-11-06

205004 / 1

Active Ingredient

BORTEZOMIB

Application Number

205004

Product Number

1

Dosage Form

-

Strength

3.5MG/VIAL

Approval Date

2017-11-06

Regulatory Status

Discontinued

2002
31 Dec
Discontinued Application: 75836

Drug Name

CALCITRIOL

Product Number

1

Dosage Form

-

Strength

0.001MG/ML

Approval Date

2002-12-31

75836 / 1

Active Ingredient

CALCITRIOL

Application Number

75836

Product Number

1

Dosage Form

-

Strength

0.001MG/ML

Approval Date

2002-12-31

Regulatory Status

Discontinued

2002
31 Dec
Discontinued Application: 75836

Drug Name

CALCITRIOL

Product Number

2

Dosage Form

-

Strength

0.002MG/ML

Approval Date

2002-12-31

75836 / 2

Active Ingredient

CALCITRIOL

Application Number

75836

Product Number

2

Dosage Form

-

Strength

0.002MG/ML

Approval Date

2002-12-31

Regulatory Status

Discontinued

2021
17 Jun
Discontinued Application: 208418

Drug Name

CALCIUM GLUCONATE IN SODIUM CHLORIDE

Product Number

4

Dosage Form

-

Strength

1GM/50ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2021-06-17

208418 / 4

Active Ingredient

CALCIUM GLUCONATE

Application Number

208418

Product Number

4

Dosage Form

-

Strength

1GM/50ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2021-06-17

Regulatory Status

Discontinued

2021
17 Jun
Discontinued Application: 208418

Drug Name

CALCIUM GLUCONATE IN SODIUM CHLORIDE

Product Number

5

Dosage Form

-

Strength

2GM/100ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2021-06-17

208418 / 5

Active Ingredient

CALCIUM GLUCONATE

Application Number

208418

Product Number

5

Dosage Form

-

Strength

2GM/100ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2021-06-17

Regulatory Status

Discontinued

2004
14 Oct
Discontinued Application: 76235

Drug Name

CARBOPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2004-10-14

76235 / 1

Active Ingredient

CARBOPLATIN

Application Number

76235

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2004-10-14

Regulatory Status

Discontinued

2004
14 Oct
Discontinued Application: 76235

Drug Name

CARBOPLATIN

Product Number

2

Dosage Form

-

Strength

150MG/VIAL

Approval Date

2004-10-14

76235 / 2

Active Ingredient

CARBOPLATIN

Application Number

76235

Product Number

2

Dosage Form

-

Strength

150MG/VIAL

Approval Date

2004-10-14

Regulatory Status

Discontinued

2004
14 Oct
Discontinued Application: 76235

Drug Name

CARBOPLATIN

Product Number

3

Dosage Form

-

Strength

450MG/VIAL

Approval Date

2004-10-14

76235 / 3

Active Ingredient

CARBOPLATIN

Application Number

76235

Product Number

3

Dosage Form

-

Strength

450MG/VIAL

Approval Date

2004-10-14

Regulatory Status

Discontinued

2004
21 Oct
Discontinued Application: 77247

Drug Name

CARBOPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2004-10-21

77247 / 1

Active Ingredient

CARBOPLATIN

Application Number

77247

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2004-10-21

Regulatory Status

Discontinued

2004
21 Oct
Discontinued Application: 77247

Drug Name

CARBOPLATIN

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2004-10-21

77247 / 2

Active Ingredient

CARBOPLATIN

Application Number

77247

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2004-10-21

Regulatory Status

Discontinued

2004
21 Oct
Discontinued Application: 77247

Drug Name

CARBOPLATIN

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2004-10-21

77247 / 3

Active Ingredient

CARBOPLATIN

Application Number

77247

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2004-10-21

Regulatory Status

Discontinued

2006
15 Feb
Discontinued Application: 77266

Drug Name

CARBOPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2006-02-15

77266 / 1

Active Ingredient

CARBOPLATIN

Application Number

77266

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2006-02-15

Regulatory Status

Discontinued

2006
15 Feb
Discontinued Application: 77266

Drug Name

CARBOPLATIN

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2006-02-15

77266 / 2

Active Ingredient

CARBOPLATIN

Application Number

77266

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2006-02-15

Regulatory Status

Discontinued

2006
29 Sep
Discontinued Application: 77432

Drug Name

CARBOPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2006-09-29

77432 / 1

Active Ingredient

CARBOPLATIN

Application Number

77432

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2006-09-29

Regulatory Status

Discontinued

2006
29 Sep
Discontinued Application: 77432

Drug Name

CARBOPLATIN

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2006-09-29

77432 / 2

Active Ingredient

CARBOPLATIN

Application Number

77432

Product Number

2

Dosage Form

-

Strength

150MG/15ML (10MG/ML)

Approval Date

2006-09-29

Regulatory Status

Discontinued

2006
29 Sep
Discontinued Application: 77432

Drug Name

CARBOPLATIN

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2006-09-29

77432 / 3

Active Ingredient

CARBOPLATIN

Application Number

77432

Product Number

3

Dosage Form

-

Strength

450MG/45ML (10MG/ML)

Approval Date

2006-09-29

Regulatory Status

Discontinued

1998
14 Aug
Discontinued Application: 64169

Drug Name

CEFAZOLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-08-14

64169 / 1

Active Ingredient

CEFAZOLIN SODIUM

Application Number

64169

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-08-14

Regulatory Status

Discontinued

1998
14 Aug
Discontinued Application: 64169

Drug Name

CEFAZOLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-08-14

64169 / 2

Active Ingredient

CEFAZOLIN SODIUM

Application Number

64169

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-08-14

Regulatory Status

Discontinued

1998
18 Mar
Discontinued Application: 64170

Drug Name

CEFAZOLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-03-18

64170 / 1

Active Ingredient

CEFAZOLIN SODIUM

Application Number

64170

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-03-18

Regulatory Status

Discontinued

1998
18 Mar
Discontinued Application: 64170

Drug Name

CEFAZOLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 20GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-03-18

64170 / 2

Active Ingredient

CEFAZOLIN SODIUM

Application Number

64170

Product Number

2

Dosage Form

-

Strength

EQ 20GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-03-18

Regulatory Status

Discontinued

2000
24 Mar
Discontinued Application: 64200

Drug Name

CEFOTAXIME

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2000-03-24

64200 / 1

Active Ingredient

CEFOTAXIME SODIUM

Application Number

64200

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2000-03-24

Regulatory Status

Discontinued

2000
24 Mar
Discontinued Application: 64200

Drug Name

CEFOTAXIME

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2000-03-24

64200 / 2

Active Ingredient

CEFOTAXIME SODIUM

Application Number

64200

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2000-03-24

Regulatory Status

Discontinued

2000
24 Mar
Discontinued Application: 64200

Drug Name

CEFOTAXIME

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2000-03-24

64200 / 3

Active Ingredient

CEFOTAXIME SODIUM

Application Number

64200

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2000-03-24

Regulatory Status

Discontinued

2000
24 Mar
Discontinued Application: 64201

Drug Name

CEFOTAXIME

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2000-03-24

64201 / 1

Active Ingredient

CEFOTAXIME SODIUM

Application Number

64201

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2000-03-24

Regulatory Status

Discontinued

2000
24 Mar
Discontinued Application: 64201

Drug Name

CEFOTAXIME

Product Number

2

Dosage Form

-

Strength

EQ 20GM BASE/VIAL

Approval Date

2000-03-24

64201 / 2

Active Ingredient

CEFOTAXIME SODIUM

Application Number

64201

Product Number

2

Dosage Form

-

Strength

EQ 20GM BASE/VIAL

Approval Date

2000-03-24

Regulatory Status

Discontinued

2007
09 Aug
Discontinued Application: 65375

Drug Name

CEFOTETAN

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2007-08-09

65375 / 1

Active Ingredient

CEFOTETAN DISODIUM

Application Number

65375

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2007-08-09

Regulatory Status

Discontinued

2000
03 Jul
Discontinued Application: 65011

Drug Name

CEFOXITIN

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2000-07-03

65011 / 1

Active Ingredient

CEFOXITIN SODIUM

Application Number

65011

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2000-07-03

Regulatory Status

Discontinued

2000
03 Jul
Discontinued Application: 65012

Drug Name

CEFOXITIN

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2000-07-03

65012 / 1

Active Ingredient

CEFOXITIN SODIUM

Application Number

65012

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2000-07-03

Regulatory Status

Discontinued

2000
03 Jul
Discontinued Application: 65012

Drug Name

CEFOXITIN

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2000-07-03

65012 / 2

Active Ingredient

CEFOXITIN SODIUM

Application Number

65012

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2000-07-03

Regulatory Status

Discontinued

2006
15 Feb
Discontinued Application: 65245

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2006-02-15

65245 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65245

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL

Approval Date

2006-02-15

Regulatory Status

Discontinued

2006
15 Feb
Discontinued Application: 65245

Drug Name

CEFTRIAXONE

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2006-02-15

65245 / 2

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65245

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2006-02-15

Regulatory Status

Discontinued

2006
15 Feb
Discontinued Application: 65245

Drug Name

CEFTRIAXONE

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2006-02-15

65245 / 3

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65245

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2006-02-15

Regulatory Status

Discontinued

2006
15 Feb
Discontinued Application: 65245

Drug Name

CEFTRIAXONE

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2006-02-15

65245 / 4

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65245

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2006-02-15

Regulatory Status

Discontinued

2006
15 Feb
Discontinued Application: 65252

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2006-02-15

65252 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65252

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2006-02-15

Regulatory Status

Discontinued

2001
30 May
Discontinued Application: 65001

Drug Name

CEFUROXIME SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

2001-05-30

65001 / 1

Active Ingredient

CEFUROXIME SODIUM

Application Number

65001

Product Number

1

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

2001-05-30

Regulatory Status

Discontinued

2001
30 May
Discontinued Application: 65001

Drug Name

CEFUROXIME SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 1.5GM BASE/VIAL

Approval Date

2001-05-30

65001 / 2

Active Ingredient

CEFUROXIME SODIUM

Application Number

65001

Product Number

2

Dosage Form

-

Strength

EQ 1.5GM BASE/VIAL

Approval Date

2001-05-30

Regulatory Status

Discontinued

1998
28 Sep
Discontinued Application: 65002

Drug Name

CEFUROXIME SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 7.5GM BASE/VIAL

Approval Date

1998-09-28

65002 / 1

Active Ingredient

CEFUROXIME SODIUM

Application Number

65002

Product Number

1

Dosage Form

-

Strength

EQ 7.5GM BASE/VIAL

Approval Date

1998-09-28

Regulatory Status

Discontinued

1982
25 Aug
Discontinued Application: 62365

Drug Name

CHLORAMPHENICOL SODIUM SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

1982-08-25

62365 / 1

Active Ingredient

CHLORAMPHENICOL SODIUM SUCCINATE

Application Number

62365

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

1982-08-25

Regulatory Status

Discontinued

2006
28 Aug
Discontinued Application: 76484

Drug Name

CIPROFLOXACIN

Product Number

1

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2006-08-28

76484 / 1

Active Ingredient

CIPROFLOXACIN

Application Number

76484

Product Number

1

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2006-08-28

Regulatory Status

Discontinued

2006
28 Aug
Discontinued Application: 76484

Drug Name

CIPROFLOXACIN

Product Number

2

Dosage Form

-

Strength

400MG/40ML (10MG/ML)

Approval Date

2006-08-28

76484 / 2

Active Ingredient

CIPROFLOXACIN

Application Number

76484

Product Number

2

Dosage Form

-

Strength

400MG/40ML (10MG/ML)

Approval Date

2006-08-28

Regulatory Status

Discontinued

2007
29 Mar
Discontinued Application: 65346

Drug Name

CLINDAMYCIN PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE/ML

Approval Date

2007-03-29

65346 / 1

Active Ingredient

CLINDAMYCIN PHOSPHATE

Application Number

65346

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE/ML

Approval Date

2007-03-29

Regulatory Status

Discontinued

2007
09 May
Discontinued Application: 65347

Drug Name

CLINDAMYCIN PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE/ML

Approval Date

2007-05-09

65347 / 1

Active Ingredient

CLINDAMYCIN PHOSPHATE

Application Number

65347

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE/ML

Approval Date

2007-05-09

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 80557

Drug Name

CYANOCOBALAMIN

Product Number

2

Dosage Form

-

Strength

0.1MG/ML

Approval Date

1982-01-01

80557 / 2

Active Ingredient

CYANOCOBALAMIN

Application Number

80557

Product Number

2

Dosage Form

-

Strength

0.1MG/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

2024
01 Aug
Discontinued Application: 213396

Drug Name

DAPTOMYCIN

Product Number

1

Dosage Form

-

Strength

350MG/VIAL

Approval Date

2024-08-01

213396 / 1

Active Ingredient

DAPTOMYCIN

Application Number

213396

Product Number

1

Dosage Form

-

Strength

350MG/VIAL

Approval Date

2024-08-01

Regulatory Status

Discontinued

2001
20 Nov
Discontinued Application: 65034

Drug Name

DAUNORUBICIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/VIAL

Approval Date

2001-11-20

65034 / 1

Active Ingredient

DAUNORUBICIN HYDROCHLORIDE

Application Number

65034

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/VIAL

Approval Date

2001-11-20

Regulatory Status

Discontinued

1984
25 Jan
Discontinued Application: 88469

Drug Name

DEXAMETHASONE

Product Number

1

Dosage Form

-

Strength

EQ 10MG PHOSPHATE/ML

Approval Date

1984-01-25

88469 / 1

Active Ingredient

DEXAMETHASONE SODIUM PHOSPHATE

Application Number

88469

Product Number

1

Dosage Form

-

Strength

EQ 10MG PHOSPHATE/ML

Approval Date

1984-01-25

Regulatory Status

Discontinued

1994
04 Aug
Discontinued Application: 19034

Drug Name

DILAUDID-HP

Product Number

2

Dosage Form

-

Strength

250MG/VIAL

Approval Date

1994-08-04

19034 / 2

Active Ingredient

HYDROMORPHONE HYDROCHLORIDE

Application Number

19034

Product Number

2

Dosage Form

-

Strength

250MG/VIAL

Approval Date

1994-08-04

Regulatory Status

Discontinued

1989
02 Oct
Discontinued Application: 19627

Drug Name

DIPRIVAN

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

1989-10-02

19627 / 1

Active Ingredient

PROPOFOL

Application Number

19627

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

1989-10-02

Regulatory Status

Discontinued

1998
30 Sep
Discontinued Application: 74956

Drug Name

DIPYRIDAMOLE

Product Number

1

Dosage Form

-

Strength

5MG/ML

Approval Date

1998-09-30

74956 / 1

Active Ingredient

DIPYRIDAMOLE

Application Number

74956

Product Number

1

Dosage Form

-

Strength

5MG/ML

Approval Date

1998-09-30

Regulatory Status

Discontinued

2007
15 Oct
Discontinued Application: 65408

Drug Name

EPIRUBICIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG/5ML (2MG/ML)

Approval Date

2007-10-15

65408 / 1

Active Ingredient

EPIRUBICIN HYDROCHLORIDE

Application Number

65408

Product Number

1

Dosage Form

-

Strength

10MG/5ML (2MG/ML)

Approval Date

2007-10-15

Regulatory Status

Discontinued

2007
15 Oct
Discontinued Application: 65408

Drug Name

EPIRUBICIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG/25ML (2MG/ML)

Approval Date

2007-10-15

65408 / 2

Active Ingredient

EPIRUBICIN HYDROCHLORIDE

Application Number

65408

Product Number

2

Dosage Form

-

Strength

50MG/25ML (2MG/ML)

Approval Date

2007-10-15

Regulatory Status

Discontinued

2007
15 Oct
Discontinued Application: 65408

Drug Name

EPIRUBICIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

150MG/75ML (2MG/ML)

Approval Date

2007-10-15

65408 / 3

Active Ingredient

EPIRUBICIN HYDROCHLORIDE

Application Number

65408

Product Number

3

Dosage Form

-

Strength

150MG/75ML (2MG/ML)

Approval Date

2007-10-15

Regulatory Status

Discontinued

2007
15 Oct
Discontinued Application: 65408

Drug Name

EPIRUBICIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

200MG/100ML (2MG/ML)

Approval Date

2007-10-15

65408 / 4

Active Ingredient

EPIRUBICIN HYDROCHLORIDE

Application Number

65408

Product Number

4

Dosage Form

-

Strength

200MG/100ML (2MG/ML)

Approval Date

2007-10-15

Regulatory Status

Discontinued

2007
20 Aug
Discontinued Application: 65411

Drug Name

EPIRUBICIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

200MG/100ML (2MG/ML)

Approval Date

2007-08-20

65411 / 1

Active Ingredient

EPIRUBICIN HYDROCHLORIDE

Application Number

65411

Product Number

1

Dosage Form

-

Strength

200MG/100ML (2MG/ML)

Approval Date

2007-08-20

Regulatory Status

Discontinued

2007
20 Aug
Discontinued Application: 65411

Drug Name

EPIRUBICIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG/25ML (2MG/ML)

Approval Date

2007-08-20

65411 / 2

Active Ingredient

EPIRUBICIN HYDROCHLORIDE

Application Number

65411

Product Number

2

Dosage Form

-

Strength

50MG/25ML (2MG/ML)

Approval Date

2007-08-20

Regulatory Status

Discontinued

2005
02 May
Discontinued Application: 76573

Drug Name

ESMOLOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2005-05-02

76573 / 1

Active Ingredient

ESMOLOL HYDROCHLORIDE

Application Number

76573

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2005-05-02

Regulatory Status

Discontinued

2023
23 Aug
Discontinued Application: 76573

Drug Name

ESMOLOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

20MG/ML

Approval Date

2023-08-23

76573 / 2

Active Ingredient

ESMOLOL HYDROCHLORIDE

Application Number

76573

Product Number

2

Dosage Form

-

Strength

20MG/ML

Approval Date

2023-08-23

Regulatory Status

Discontinued

1999
24 Mar
Discontinued Application: 40291

Drug Name

FLUOROURACIL

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

1999-03-24

40291 / 1

Active Ingredient

FLUOROURACIL

Application Number

40291

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

1999-03-24

Regulatory Status

Discontinued

2000
15 Nov
Discontinued Application: 40379

Drug Name

FLUOROURACIL

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

2000-11-15

40379 / 1

Active Ingredient

FLUOROURACIL

Application Number

40379

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

2000-11-15

Regulatory Status

Discontinued

1982
04 Mar
Discontinued Application: 62356

Drug Name

GENTAMICIN SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

1982-03-04

62356 / 1

Active Ingredient

GENTAMICIN SULFATE

Application Number

62356

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

1982-03-04

Regulatory Status

Discontinued

1982
04 Mar
Discontinued Application: 62356

Drug Name

GENTAMICIN SULFATE

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE/ML

Approval Date

1982-03-04

62356 / 2

Active Ingredient

GENTAMICIN SULFATE

Application Number

62356

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE/ML

Approval Date

1982-03-04

Regulatory Status

Discontinued

2019
01 Jul
Discontinued Application: 210356

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2019-07-01

210356 / 1

Active Ingredient

HALOPERIDOL LACTATE

Application Number

210356

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2019-07-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 17029

Drug Name

HEPARIN SODIUM

Product Number

2

Dosage Form

-

Strength

5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

17029 / 2

Active Ingredient

HEPARIN SODIUM

Application Number

17029

Product Number

2

Dosage Form

-

Strength

5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 17651

Drug Name

HEPARIN SODIUM

Product Number

3

Dosage Form

-

Strength

10,000 UNITS/ML

Approval Date

1982-01-01

17651 / 3

Active Ingredient

HEPARIN SODIUM

Application Number

17651

Product Number

3

Dosage Form

-

Strength

10,000 UNITS/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 17651

Drug Name

HEPARIN SODIUM

Product Number

5

Dosage Form

-

Strength

1,000 UNITS/ML

Approval Date

1982-01-01

17651 / 5

Active Ingredient

HEPARIN SODIUM

Application Number

17651

Product Number

5

Dosage Form

-

Strength

1,000 UNITS/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 17651

Drug Name

HEPARIN SODIUM

Product Number

8

Dosage Form

-

Strength

20,000 UNITS/ML

Approval Date

1982-01-01

17651 / 8

Active Ingredient

HEPARIN SODIUM

Application Number

17651

Product Number

8

Dosage Form

-

Strength

20,000 UNITS/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

2017
24 Aug
Discontinued Application: 17029

Drug Name

HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5%

Product Number

21

Dosage Form

-

Strength

40 UNITS/ML

Approval Date

2017-08-24

17029 / 21

Active Ingredient

HEPARIN SODIUM

Application Number

17029

Product Number

21

Dosage Form

-

Strength

40 UNITS/ML

Approval Date

2017-08-24

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 87329

Drug Name

HYDROXYZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

1982-01-01

87329 / 1

Active Ingredient

HYDROXYZINE HYDROCHLORIDE

Application Number

87329

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 87329

Drug Name

HYDROXYZINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG/ML

Approval Date

1982-01-01

87329 / 2

Active Ingredient

HYDROXYZINE HYDROCHLORIDE

Application Number

87329

Product Number

2

Dosage Form

-

Strength

50MG/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

1983
31 Mar
Discontinued Application: 88184

Drug Name

HYDROXYZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

1983-03-31

88184 / 1

Active Ingredient

HYDROXYZINE HYDROCHLORIDE

Application Number

88184

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

1983-03-31

Regulatory Status

Discontinued

1983
31 Mar
Discontinued Application: 88185

Drug Name

HYDROXYZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

1983-03-31

88185 / 1

Active Ingredient

HYDROXYZINE HYDROCHLORIDE

Application Number

88185

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

1983-03-31

Regulatory Status

Discontinued

2009
04 Aug
Discontinued Application: 65440

Drug Name

IDARUBICIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG/5ML (1MG/ML)

Approval Date

2009-08-04

65440 / 1

Active Ingredient

IDARUBICIN HYDROCHLORIDE

Application Number

65440

Product Number

1

Dosage Form

-

Strength

5MG/5ML (1MG/ML)

Approval Date

2009-08-04

Regulatory Status

Discontinued

2009
04 Aug
Discontinued Application: 65440

Drug Name

IDARUBICIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG/10ML (1MG/ML)

Approval Date

2009-08-04

65440 / 2

Active Ingredient

IDARUBICIN HYDROCHLORIDE

Application Number

65440

Product Number

2

Dosage Form

-

Strength

10MG/10ML (1MG/ML)

Approval Date

2009-08-04

Regulatory Status

Discontinued

2009
04 Aug
Discontinued Application: 65440

Drug Name

IDARUBICIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

20MG/20ML (1MG/ML)

Approval Date

2009-08-04

65440 / 3

Active Ingredient

IDARUBICIN HYDROCHLORIDE

Application Number

65440

Product Number

3

Dosage Form

-

Strength

20MG/20ML (1MG/ML)

Approval Date

2009-08-04

Regulatory Status

Discontinued

2009
22 Sep
Discontinued Application: 90181

Drug Name

IFOSFAMIDE

Product Number

1

Dosage Form

-

Strength

1GM/20ML (50MG/ML)

Approval Date

2009-09-22

90181 / 1

Active Ingredient

IFOSFAMIDE

Application Number

90181

Product Number

1

Dosage Form

-

Strength

1GM/20ML (50MG/ML)

Approval Date

2009-09-22

Regulatory Status

Discontinued

2009
22 Sep
Discontinued Application: 90181

Drug Name

IFOSFAMIDE

Product Number

2

Dosage Form

-

Strength

3GM/60ML (50MG/ML)

Approval Date

2009-09-22

90181 / 2

Active Ingredient

IFOSFAMIDE

Application Number

90181

Product Number

2

Dosage Form

-

Strength

3GM/60ML (50MG/ML)

Approval Date

2009-09-22

Regulatory Status

Discontinued

1997
02 Apr
Discontinued Application: 74679

Drug Name

IOPAMIDOL-250

Product Number

1

Dosage Form

-

Strength

51%

Approval Date

1997-04-02

74679 / 1

Active Ingredient

IOPAMIDOL

Application Number

74679

Product Number

1

Dosage Form

-

Strength

51%

Approval Date

1997-04-02

Regulatory Status

Discontinued

1997
02 Apr
Discontinued Application: 74679

Drug Name

IOPAMIDOL-300

Product Number

2

Dosage Form

-

Strength

61%

Approval Date

1997-04-02

74679 / 2

Active Ingredient

IOPAMIDOL

Application Number

74679

Product Number

2

Dosage Form

-

Strength

61%

Approval Date

1997-04-02

Regulatory Status

Discontinued

1997
02 Apr
Discontinued Application: 74679

Drug Name

IOPAMIDOL-370

Product Number

3

Dosage Form

-

Strength

76%

Approval Date

1997-04-02

74679 / 3

Active Ingredient

IOPAMIDOL

Application Number

74679

Product Number

3

Dosage Form

-

Strength

76%

Approval Date

1997-04-02

Regulatory Status

Discontinued

2008
27 Feb
Discontinued Application: 78188

Drug Name

IRINOTECAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2008-02-27

78188 / 1

Active Ingredient

IRINOTECAN HYDROCHLORIDE

Application Number

78188

Product Number

1

Dosage Form

-

Strength

40MG/2ML (20MG/ML)

Approval Date

2008-02-27

Regulatory Status

Discontinued

2008
27 Feb
Discontinued Application: 78188

Drug Name

IRINOTECAN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

100MG/5ML (20MG/ML)

Approval Date

2008-02-27

78188 / 2

Active Ingredient

IRINOTECAN HYDROCHLORIDE

Application Number

78188

Product Number

2

Dosage Form

-

Strength

100MG/5ML (20MG/ML)

Approval Date

2008-02-27

Regulatory Status

Discontinued

2022
08 Sep
Discontinued Application: 211869

Drug Name

ISOSULFAN BLUE

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2022-09-08

211869 / 1

Active Ingredient

ISOSULFAN BLUE

Application Number

211869

Product Number

1

Dosage Form

-

Strength

50MG/5ML (10MG/ML)

Approval Date

2022-09-08

Regulatory Status

Discontinued

2002
17 Dec
Discontinued Application: 65111

Drug Name

KANAMYCIN SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/2ML

Approval Date

2002-12-17

65111 / 1

Active Ingredient

KANAMYCIN SULFATE

Application Number

65111

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/2ML

Approval Date

2002-12-17

Regulatory Status

Discontinued

2002
17 Dec
Discontinued Application: 65111

Drug Name

KANAMYCIN SULFATE

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/3ML

Approval Date

2002-12-17

65111 / 2

Active Ingredient

KANAMYCIN SULFATE

Application Number

65111

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/3ML

Approval Date

2002-12-17

Regulatory Status

Discontinued

2015
07 Oct
Discontinued Application: 203242

Drug Name

KETOROLAC TROMETHAMINE

Product Number

1

Dosage Form

-

Strength

15MG/ML

Approval Date

2015-10-07

203242 / 1

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

203242

Product Number

1

Dosage Form

-

Strength

15MG/ML

Approval Date

2015-10-07

Regulatory Status

Discontinued

2011
03 Jun
Discontinued Application: 90491

Drug Name

LETROZOLE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2011-06-03

90491 / 1

Active Ingredient

LETROZOLE

Application Number

90491

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2011-06-03

Regulatory Status

Discontinued

2010
26 May
Discontinued Application: 90813

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

500MG/5ML (100MG/ML)

Approval Date

2010-05-26

90813 / 1

Active Ingredient

LEVETIRACETAM

Application Number

90813

Product Number

1

Dosage Form

-

Strength

500MG/5ML (100MG/ML)

Approval Date

2010-05-26

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 80722

Drug Name

METARAMINOL BITARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

1982-01-01

80722 / 1

Active Ingredient

METARAMINOL BITARTRATE

Application Number

80722

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

1999
26 Feb
Discontinued Application: 40265

Drug Name

METHOTREXATE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE/ML

Approval Date

1999-02-26

40265 / 1

Active Ingredient

METHOTREXATE SODIUM

Application Number

40265

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE/ML

Approval Date

1999-02-26

Regulatory Status

Discontinued

1999
26 Feb
Discontinued Application: 40263

Drug Name

METHOTREXATE SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE/10ML (EQ 25MG BASE/ML)

Approval Date

1999-02-26

40263 / 2

Active Ingredient

METHOTREXATE SODIUM

Application Number

40263

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE/10ML (EQ 25MG BASE/ML)

Approval Date

1999-02-26

Regulatory Status

Discontinued

2017
28 Mar
Discontinued Application: 208878

Drug Name

MIDAZOLAM HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2017-03-28

208878 / 1

Active Ingredient

MIDAZOLAM HYDROCHLORIDE

Application Number

208878

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/ML

Approval Date

2017-03-28

Regulatory Status

Discontinued

2013
30 Oct
Discontinued Application: 204223

Drug Name

MORPHINE SULFATE

Product Number

3

Dosage Form

-

Strength

5MG/ML (5MG/ML)

Approval Date

2013-10-30

204223 / 3

Active Ingredient

MORPHINE SULFATE

Application Number

204223

Product Number

3

Dosage Form

-

Strength

5MG/ML (5MG/ML)

Approval Date

2013-10-30

Regulatory Status

Discontinued

2013
30 Oct
Discontinued Application: 204223

Drug Name

MORPHINE SULFATE

Product Number

4

Dosage Form

-

Strength

8MG/ML (8MG/ML)

Approval Date

2013-10-30

204223 / 4

Active Ingredient

MORPHINE SULFATE

Application Number

204223

Product Number

4

Dosage Form

-

Strength

8MG/ML (8MG/ML)

Approval Date

2013-10-30

Regulatory Status

Discontinued

2022
29 Jun
Discontinued Application: 215370

Drug Name

MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5

Product Number

1

Dosage Form

-

Strength

30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML

Approval Date

2022-06-29

215370 / 1

Active Ingredient

MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE

Application Number

215370

Product Number

1

Dosage Form

-

Strength

30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML

Approval Date

2022-06-29

Regulatory Status

Discontinued

1996
24 Sep
Discontinued Application: 20533

Drug Name

NAROPIN

Product Number

12

Dosage Form

-

Strength

75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-09-24

20533 / 12

Active Ingredient

ROPIVACAINE HYDROCHLORIDE

Application Number

20533

Product Number

12

Dosage Form

-

Strength

75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-09-24

Regulatory Status

Discontinued

1998
01 May
Discontinued Application: 20533

Drug Name

NAROPIN

Product Number

13

Dosage Form

-

Strength

50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-05-01

20533 / 13

Active Ingredient

ROPIVACAINE HYDROCHLORIDE

Application Number

20533

Product Number

13

Dosage Form

-

Strength

50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-05-01

Regulatory Status

Discontinued

1996
22 Mar
Discontinued Application: 19887

Drug Name

NEBUPENT

Product Number

2

Dosage Form

-

Strength

600MG/VIAL

Approval Date

1996-03-22

19887 / 2

Active Ingredient

PENTAMIDINE ISETHIONATE

Application Number

19887

Product Number

2

Dosage Form

-

Strength

600MG/VIAL

Approval Date

1996-03-22

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 9435

Drug Name

NESACAINE

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

1982-01-01

9435 / 1

Active Ingredient

CHLOROPROCAINE HYDROCHLORIDE

Application Number

9435

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 9435

Drug Name

NESACAINE-MPF

Product Number

3

Dosage Form

-

Strength

2%

Approval Date

1982-01-01

9435 / 3

Active Ingredient

CHLOROPROCAINE HYDROCHLORIDE

Application Number

9435

Product Number

3

Dosage Form

-

Strength

2%

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 9435

Drug Name

NESACAINE-MPF

Product Number

4

Dosage Form

-

Strength

3%

Approval Date

1982-01-01

9435 / 4

Active Ingredient

CHLOROPROCAINE HYDROCHLORIDE

Application Number

9435

Product Number

4

Dosage Form

-

Strength

3%

Approval Date

1982-01-01

Regulatory Status

Discontinued

2017
31 Jan
Discontinued Application: 90030

Drug Name

OXALIPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/10ML (5MG/ML)

Approval Date

2017-01-31

90030 / 1

Active Ingredient

OXALIPLATIN

Application Number

90030

Product Number

1

Dosage Form

-

Strength

50MG/10ML (5MG/ML)

Approval Date

2017-01-31

Regulatory Status

Discontinued

2017
31 Jan
Discontinued Application: 90030

Drug Name

OXALIPLATIN

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2017-01-31

90030 / 2

Active Ingredient

OXALIPLATIN

Application Number

90030

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2017-01-31

Regulatory Status

Discontinued

2017
31 Jan
Discontinued Application: 90030

Drug Name

OXALIPLATIN

Product Number

3

Dosage Form

-

Strength

200MG/40ML (5MG/ML)

Approval Date

2017-01-31

90030 / 3

Active Ingredient

OXALIPLATIN

Application Number

90030

Product Number

3

Dosage Form

-

Strength

200MG/40ML (5MG/ML)

Approval Date

2017-01-31

Regulatory Status

Discontinued

2017
21 Nov
Discontinued Application: 208109

Drug Name

PALONOSETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)

Approval Date

2017-11-21

208109 / 1

Active Ingredient

PALONOSETRON HYDROCHLORIDE

Application Number

208109

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)

Approval Date

2017-11-21

Regulatory Status

Discontinued

2002
06 May
Discontinued Application: 75773

Drug Name

PAMIDRONATE DISODIUM

Product Number

1

Dosage Form

-

Strength

30MG/VIAL

Approval Date

2002-05-06

75773 / 1

Active Ingredient

PAMIDRONATE DISODIUM

Application Number

75773

Product Number

1

Dosage Form

-

Strength

30MG/VIAL

Approval Date

2002-05-06

Regulatory Status

Discontinued

2002
06 May
Discontinued Application: 75773

Drug Name

PAMIDRONATE DISODIUM

Product Number

2

Dosage Form

-

Strength

90MG/VIAL

Approval Date

2002-05-06

75773 / 2

Active Ingredient

PAMIDRONATE DISODIUM

Application Number

75773

Product Number

2

Dosage Form

-

Strength

90MG/VIAL

Approval Date

2002-05-06

Regulatory Status

Discontinued

2002
17 May
Discontinued Application: 76207

Drug Name

PAMIDRONATE DISODIUM

Product Number

1

Dosage Form

-

Strength

30MG/10ML (3MG/ML)

Approval Date

2002-05-17

76207 / 1

Active Ingredient

PAMIDRONATE DISODIUM

Application Number

76207

Product Number

1

Dosage Form

-

Strength

30MG/10ML (3MG/ML)

Approval Date

2002-05-17

Regulatory Status

Discontinued

2002
17 May
Discontinued Application: 76207

Drug Name

PAMIDRONATE DISODIUM

Product Number

2

Dosage Form

-

Strength

90MG/10ML (9MG/ML)

Approval Date

2002-05-17

76207 / 2

Active Ingredient

PAMIDRONATE DISODIUM

Application Number

76207

Product Number

2

Dosage Form

-

Strength

90MG/10ML (9MG/ML)

Approval Date

2002-05-17

Regulatory Status

Discontinued

1985
31 May
Discontinued Application: 89003

Drug Name

PHENYTOIN SODIUM

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

1985-05-31

89003 / 1

Active Ingredient

PHENYTOIN SODIUM

Application Number

89003

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

1985-05-31

Regulatory Status

Discontinued

2018
11 May
Discontinued Application: 206204

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL

Approval Date

2018-05-11

206204 / 1

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

206204

Product Number

1

Dosage Form

-

Strength

EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL

Approval Date

2018-05-11

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 80225

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

2MEQ/ML

Approval Date

1982-01-01

80225 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

80225

Product Number

1

Dosage Form

-

Strength

2MEQ/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 80225

Drug Name

POTASSIUM CHLORIDE

Product Number

3

Dosage Form

-

Strength

3MEQ/ML

Approval Date

1982-01-01

80225 / 3

Active Ingredient

POTASSIUM CHLORIDE

Application Number

80225

Product Number

3

Dosage Form

-

Strength

3MEQ/ML

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
20 Oct
Discontinued Application: 87817

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

2MEQ/ML

Approval Date

1982-10-20

87817 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

87817

Product Number

1

Dosage Form

-

Strength

2MEQ/ML

Approval Date

1982-10-20

Regulatory Status

Discontinued

2021
09 Nov
Discontinued Application: 211428

Drug Name

POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGERS IN PLASTIC CONTAINER

Product Number

1

Dosage Form

-

Strength

20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML

Approval Date

2021-11-09

211428 / 1

Active Ingredient

CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE

Application Number

211428

Product Number

1

Dosage Form

-

Strength

20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML

Approval Date

2021-11-09

Regulatory Status

Discontinued

2025
10 Feb
Discontinued Application: 218779

Drug Name

SELENIOUS ACID

Product Number

1

Dosage Form

-

Strength

EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML)

Approval Date

2025-02-10

218779 / 1

Active Ingredient

SELENIOUS ACID

Application Number

218779

Product Number

1

Dosage Form

-

Strength

EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML)

Approval Date

2025-02-10

Regulatory Status

Discontinued

1987
15 Apr
Discontinued Application: 71202

Drug Name

SENSORCAINE

Product Number

1

Dosage Form

-

Strength

0.75%

Approval Date

1987-04-15

71202 / 1

Active Ingredient

BUPIVACAINE HYDROCHLORIDE

Application Number

71202

Product Number

1

Dosage Form

-

Strength

0.75%

Approval Date

1987-04-15

Regulatory Status

Discontinued

2009
18 Sep
Discontinued Application: 79240

Drug Name

SUMATRIPTAN SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)

Approval Date

2009-09-18

79240 / 1

Active Ingredient

SUMATRIPTAN SUCCINATE

Application Number

79240

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)

Approval Date

2009-09-18

Regulatory Status

Discontinued

2009
18 Sep
Discontinued Application: 79240

Drug Name

SUMATRIPTAN SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

Approval Date

2009-09-18

79240 / 2

Active Ingredient

SUMATRIPTAN SUCCINATE

Application Number

79240

Product Number

2

Dosage Form

-

Strength

EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

Approval Date

2009-09-18

Regulatory Status

Discontinued

2001
20 Sep
Discontinued Application: 75698

Drug Name

THIOTEPA

Product Number

1

Dosage Form

-

Strength

15MG/VIAL

Approval Date

2001-09-20

75698 / 1

Active Ingredient

THIOTEPA

Application Number

75698

Product Number

1

Dosage Form

-

Strength

15MG/VIAL

Approval Date

2001-09-20

Regulatory Status

Discontinued

2016
01 Dec
Discontinued Application: 205645

Drug Name

TIGECYCLINE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2016-12-01

205645 / 1

Active Ingredient

TIGECYCLINE

Application Number

205645

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2016-12-01

Regulatory Status

Discontinued

2010
29 Nov
Discontinued Application: 91376

Drug Name

TOPOTECAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/VIAL

Approval Date

2010-11-29

91376 / 1

Active Ingredient

TOPOTECAN HYDROCHLORIDE

Application Number

91376

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/VIAL

Approval Date

2010-11-29

Regulatory Status

Discontinued

2012
02 Mar
Discontinued Application: 91596

Drug Name

TRANEXAMIC ACID

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2012-03-02

91596 / 1

Active Ingredient

TRANEXAMIC ACID

Application Number

91596

Product Number

1

Dosage Form

-

Strength

100MG/ML

Approval Date

2012-03-02

Regulatory Status

Discontinued

2012
18 Jun
Discontinued Application: 65453

Drug Name

VANCOMYCIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 125MG BASE

Approval Date

2012-06-18

65453 / 1

Active Ingredient

VANCOMYCIN HYDROCHLORIDE

Application Number

65453

Product Number

1

Dosage Form

-

Strength

EQ 125MG BASE

Approval Date

2012-06-18

Regulatory Status

Discontinued

2012
18 Jun
Discontinued Application: 65453

Drug Name

VANCOMYCIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2012-06-18

65453 / 2

Active Ingredient

VANCOMYCIN HYDROCHLORIDE

Application Number

65453

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2012-06-18

Regulatory Status

Discontinued

2002
20 Dec
Discontinued Application: 76296

Drug Name

VINCRISTINE SULFATE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2002-12-20

76296 / 1

Active Ingredient

VINCRISTINE SULFATE

Application Number

76296

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2002-12-20

Regulatory Status

Discontinued

2003
28 Oct
Discontinued Application: 76401

Drug Name

VINCRISTINE SULFATE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2003-10-28

76401 / 1

Active Ingredient

VINCRISTINE SULFATE

Application Number

76401

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2003-10-28

Regulatory Status

Discontinued

2005
18 Apr
Discontinued Application: 76849

Drug Name

VINORELBINE TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2005-04-18

76849 / 1

Active Ingredient

VINORELBINE TARTRATE

Application Number

76849

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2005-04-18

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 16297

Drug Name

XYLOCAINE 1.5% W/ DEXTROSE 7.5%

Product Number

1

Dosage Form

-

Strength

1.5%

Approval Date

1982-01-01

16297 / 1

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

16297

Product Number

1

Dosage Form

-

Strength

1.5%

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 10417

Drug Name

XYLOCAINE 4% PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

4%

Approval Date

1982-01-01

10417 / 1

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

10417

Product Number

1

Dosage Form

-

Strength

4%

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 10417

Drug Name

XYLOCAINE 4% PRESERVATIVE FREE

Product Number

2

Dosage Form

-

Strength

4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

10417 / 2

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

10417

Product Number

2

Dosage Form

-

Strength

4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 16801

Drug Name

XYLOCAINE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

16801 / 1

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

16801

Product Number

1

Dosage Form

-

Strength

2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 16801

Drug Name

XYLOCAINE PRESERVATIVE FREE

Product Number

2

Dosage Form

-

Strength

4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

16801 / 2

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

16801

Product Number

2

Dosage Form

-

Strength

4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 16801

Drug Name

XYLOCAINE PRESERVATIVE FREE

Product Number

3

Dosage Form

-

Strength

10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

16801 / 3

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

16801

Product Number

3

Dosage Form

-

Strength

10% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 16801

Drug Name

XYLOCAINE PRESERVATIVE FREE

Product Number

4

Dosage Form

-

Strength

20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

16801 / 4

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

16801

Product Number

4

Dosage Form

-

Strength

20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

Regulatory Status

Discontinued

1988
19 Jan
Discontinued Application: 16801

Drug Name

XYLOCAINE PRESERVATIVE FREE

Product Number

5

Dosage Form

-

Strength

1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1988-01-19

16801 / 5

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

16801

Product Number

5

Dosage Form

-

Strength

1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1988-01-19

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 9470

Drug Name

XYLOCAINE VISCOUS

Product Number

1

Dosage Form

-

Strength

2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

9470 / 1

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

9470

Product Number

1

Dosage Form

-

Strength

2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1982-01-01

Regulatory Status

Discontinued

1982
01 Jan
Discontinued Application: 6488

Drug Name

XYLOCAINE W/ EPINEPHRINE

Product Number

3

Dosage Form

-

Strength

0.01MG/ML;2%

Approval Date

1982-01-01

6488 / 3

Active Ingredient

EPINEPHRINE; LIDOCAINE HYDROCHLORIDE

Application Number

6488

Product Number

3

Dosage Form

-

Strength

0.01MG/ML;2%

Approval Date

1982-01-01

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    581 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
146 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACYCLOVIR SODIUM

Application Number

75015

Product Number

1

Active Ingredient

ACYCLOVIR SODIUM

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit